Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy

CONTEXT: The therapeutic strategy in intermediate risk (IR) non-muscle invasive bladder cancer (NMIBC) recurring after intravesical therapy (IT) is not well defined. Most patients are usually retreated by Bacillus Calmette-Guerin (BCG). AIMS: To evaluate the efficacy of intravesical chemotherapy (IC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Urol Ann
Main Authors: Serretta, Vincenzo, Sommatino, Francesco, Gesolfo, Cristina Scalici, Franco, Vito, Cicero, Giuseppe, Allegro, Rosalinda
Formato: Artigo
Idioma:Inglês
Publicado em: Medknow Publications & Media Pvt Ltd 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4310111/
https://ncbi.nlm.nih.gov/pubmed/25657538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0974-7796.148582
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados